← Evidence map

ArticleLeukemia & lymphoma2021

Are phase III trials still important for FDA drug approval?

Mary-Elizabeth M Percival et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 33691575